Key Considerations for Cell and Gene Therapy Commercialization in Non-Orphan Indications 29/05/2024 Healthcare Access to innovation Drug discovery There are two important challenges for companies aiming to develop CGTs in mainstream indications. Partners
Miramoon Pharma Receives Orphan Drug Designation for MP-004 28/05/2024 Healthcare Access to innovation Rare diseases Innovative drugs Orphan Drug Designation is a special status granted by the FDA to drugs that are intended to treat rare diseases or... Partners - Miramoon Pharma
Atlas Molecular Pharma successfully completes phase one in humans of its treatment for Con... 28/05/2024 Healthcare Access to innovation Drug discovery Rare diseases Innovative drugs Personalized medicine The final results of ATL-001, the biotech company's lead candidate, have shown that it is able to stabilize UROIIIS and... Partners - Inveready
Biotechnology and sensor technology applied to the agri-food industry? Yes, it is possible 27/05/2024 Healthcare Access to innovation Digitalization The applied research and technological development center, TECNALIA , develops cutting-edge technologies that optimize... Partners - TECNALIA
Launch of Immunostep's New Reagent for CAR T Cell Detection 27/05/2024 Healthcare Access to innovation Drug discovery Immunostep introduces an innovative reagent for CAR T cell detection, enhancing precision and efficiency in cancer... Partners
Quibim to present three of its latest advances in oncology research at ASCO 2024 conferenc... 27/05/2024 Healthcare Access to innovation Digitalization These studies explore the use of advanced radiomics techniques and artificial intelligence-based analysis for the... Partners - Quibim SL
The Teófilo Hernando Foundation and the Spanish National Research Council join forces with... 27/05/2024 Healthcare Access to innovation Drug discovery With this agreement, the FTH takes a fine step forward in its commitment to improve people's health and quality of life. Partners - Fundación Teófilo Hernando (FTH)
Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for... 24/05/2024 Healthcare Access to innovation Innovative drugs Advanced therapies it is a medicine to improve progression-free survival and overall survival in patients with metastatic pancreatic... Partners
GENESIS Tech Transfer Boost invests €50,000 in the funding round of Ownmed Innovation, wh... 23/05/2024 Healthcare Access to innovation Financing Ownmed Innovation's technology provides an alternative to ostomy bags, allowing patients to have greater autonomy and... Partners - GENESIS Biomed
Cellab CDMO obtains a GMP certification for advanced therapy product manufacturing 22/05/2024 Healthcare Access to innovation Personalized medicine Advanced therapies The Spanish Agency for Medicines and Health Products (AEMPS) has certified compliance with the European Union Good... Partners - Cellab
